Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.52M | 4.78M | 5.06M | 5.26M | 4.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.52M | 4.78M | 5.06M | 5.26M | 4.48M |
| Cost of Revenue | 2.61M | 2.38M | 2.49M | 2.50M | 2.18M |
| Gross Profit | 2.91M | 2.40M | 2.57M | 2.76M | 2.31M |
| SG&A Expenses | 2.15M | 2.26M | 1.77M | 1.83M | 1.88M |
| Depreciation & Amortization | 364.40K | 244.50K | 189.70K | 188.90K | 190.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.12M | 4.88M | 4.44M | 4.51M | 4.25M |
| Operating Income | 395.80K | -107.00K | 615.80K | 746.90K | 234.70K |
| Income Before Tax | 56.00K | -299.30K | 533.50K | 660.10K | 133.40K |
| Income Tax Expenses | 37.00K | 58.70K | 165.30K | 238.00K | 39.90K |
| Earnings from Continuing Operations | 19.00K | -358.00K | 368.20K | 422.10K | 93.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.00K | -358.00K | 368.20K | 422.10K | 93.50K |
| EBIT | 395.80K | -107.00K | 615.80K | 746.90K | 234.70K |
| EBITDA | 833.40K | 226.00K | 854.10K | 981.40K | 471.30K |
| EPS Basic | 0.00 | -0.01 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 31.03M | 25.06M | 31.03M | 31.03M | 31.03M |
| Average Diluted Shares Outstanding | 35.08M | 25.06M | 31.03M | 31.03M | 31.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |